New vaccine combo takes on tough lung cancer in early trial
Disease control
Not yet recruiting
This early-phase study tests a new cancer vaccine (EVM14) combined with an immunotherapy drug (ivonescimab) in 13 people with advanced squamous non-small cell lung cancer that has not been treated before. The main goals are to check safety and find the right dose, while also look…
Phase: PHASE1 • Sponsor: Everest Medicines (Beijing) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC